Douglas S Auld (Douglas Auld)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Clostridium Difficile

Top Venues

Journal of medicinal chemistry

SLAS discovery : advancing life sciences R & D

ACS chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Karishma Kailass, Dominick Casalena, Lina Jenane, Gregor McEdwards, Douglas S Auld, Oleg Sadovski, Esther G Kaye, Elyse Hudson, David Nettleton, Mark A Currie, Andrew A Beharry
Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of medicinal chemistry 67 (3) (2024)
Karishma Kailass, Dominick Casalena, Lina Jenane, Gregor McEdwards, Douglas S Auld, Oleg Sadovski, Esther G Kaye, Elyse Hudson, David Nettleton, Mark A Currie, Andrew A Beharry
Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of medicinal chemistry 67 (3) (2024)
Karishma Kailass, Dominick Casalena, Lina Jenane, Gregor McEdwards, Douglas S Auld, Oleg Sadovski, Esther G Kaye, Elyse Hudson, David Nettleton, Mark A Currie, Andrew A Beharry
Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of medicinal chemistry (2024)
Karishma Kailass, Dominick Casalena, Lina Jenane, Gregor McEdwards, Douglas S Auld, Oleg Sadovski, Esther G Kaye, Elyse Hudson, David Nettleton, Mark A Currie, Andrew A Beharry
Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of medicinal chemistry 67 (3) (2024)
Karishma Kailass, Dominick Casalena, Lina Jenane, Gregor McEdwards, Douglas S Auld, Oleg Sadovski, Esther G Kaye, Elyse Hudson, David Nettleton, Mark A Currie, Andrew A Beharry
Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of medicinal chemistry 67 (3) (2024)
Karishma Kailass, Dominick Casalena, Lina Jenane, Gregor McEdwards, Douglas S Auld, Oleg Sadovski, Esther G Kaye, Elyse Hudson, David Nettleton, Mark A Currie, Andrew A Beharry
Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of medicinal chemistry 67 (3) (2024)
Nathan P Coussens, Douglas S Auld, Jonathan R Thielman, Bridget K Wagner, Jayme L Dahlin
Addressing Compound Reactivity and Aggregation Assay Interferences: Case Studies of Biochemical High-Throughput Screening Campaigns Benefiting from the National Institutes of Health Assay Guidance Manual Guidelines. SLAS discovery : advancing life sciences R & D 26 (10) (2021)
Ansgar Schuffenhauer, Nadine Schneider, Samuel Hintermann, Douglas S Auld, Jutta Blank, Simona Cotesta, Caroline Engeloch, Nikolas Fechner, Christoph Gaul, Jerome Giovannoni, Johanna M Jansen, John Joslin, Philipp Krastel, Eugen Lounkine, John Manchester, Lauren G Monovich, Anna Paola Pelliccioli, Manuel Schwarze, Michael D Shultz, Nikolaus Stiefl, Daniel K Baeschlin
Evolution of Novartis' Small Molecule Screening Deck Design. Journal of medicinal chemistry 63 (23) (2020)
Scott A Busby, Seth Carbonneau, John Concannon, Christoph E Dumelin, YounKyoung Lee, Shin Numao, Nicole Renaud, Thomas M Smith, Douglas S Auld
Advancements in Assay Technologies and Strategies to Enable Drug Discovery. ACS chemical biology 15 (10) (2020)
Douglas S Auld, Janaki Narahari, Pei-I Ho, Dominick Casalena, Vy Nguyen, Evelina Cirbaite, Doug Hughes, John Daly, Brian Webb
Characterization and Use of TurboLuc Luciferase as a Reporter for High-Throughput Assays. Biochemistry 57 (31) (2018)